Example: barber
NEW ZEALAND DATA SHEET - Medsafe Home Page
NEW ZEALAND DATA SHEET Page 1 of 20 1 PRODUCT NAME FENTANYL SANDOZ, 12.5 micrograms/hour, 25 micrograms/hour, 37.5 micrograms/hour, 50 micrograms/hour, 75 micrograms/hour, 100 micrograms/hour; Transdermal Patch 2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Tags:
Information
Domain:
Source:
Link to this page:
Documents from same domain
ADVANTAN Presentation Uses - Medsafe
www.medsafe.govt.nzADVANTAN® Data Sheet Page 1 of 9 ADVANTAN® Methylprednisolone aceponate 0.1% ointment/cream . Presentation 1 g cream or ointment contains 1 mg (0.1%) methylprednisolone aceponate.
LOXALATE 1. Product Name - Medsafe Home Page
www.medsafe.govt.nzPage 5of 21 at risk, such as the elderly, or patients with cirrhosis, or if used in combination with other medications which may cause hyponatraemia.
DATA SHEET 1 CLEXANE AND CLEXANE FORTE ... - …
www.medsafe.govt.nzNew Zealand Data Sheet June 2017 . clexane-clexane-forte-ccdsv13-dsv18-16jun17 Page 2 . 100 mg injection enoxaparin sodium 100mg (equivalent to …
SEPTANEST Articaine hydrochloride 4% with …
www.medsafe.govt.nzSEPTANEST Articaine hydrochloride 4% with adrenaline 1:100,000 Injection for local and regional dental anaesthesia DESCRIPTION SEPTANEST is a sterile aqueous solution that contains articaine hydrochloride 4% (40 mg/mL) with adrenaline acid tartrate in a 1:100,000 strength.
BOOSTRIX - Medsafe Home Page
www.medsafe.govt.nz1 BOOSTRIX®. Combined diphtheria, tetanus, acellular pertussis (dTpa) vaccine . CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET? This leaflet answers some of the common questions about BOOSTRIX vaccine.
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET Cymevene ® DS 170831 2 of 26 Caution: Cymevene must only be administered by IV infusion over 1 hour, preferably via a
Edition Draft - Medsafe
www.medsafe.govt.nzPart 4, Ed Draft Page 2 of 9 Section 1: Good Manufacturing Practice Documentation 1.1. When is GMP Documentation Required? Medsafe requires evidence of Good Manufacturing Practice (GMP) compliance for
Data Sheet 1 PRODUCT NAME 2 QUALITATIVE AND …
www.medsafe.govt.nzNew Zealand Data Sheet 31 July 2017 Lantus – insulin glargine lantus-ccdsv19-dsv11-31jul17 Page 1 Data Sheet 1 PRODUCT NAME Lantus 100 IU/mL solution for injection in 10 …
NEW ZEALAND DATA SHEET MESTINON® - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET MESTINON® MESTINON Page 4 of 8 As the severity of myasthenia gravis often fluctuates considerably, particular care is required to
DATA SHEET PREDNISONE - Medsafe
www.medsafe.govt.nz• Epilepsy and/or seizure disorder • Peptic ulceration • Previous steroid myopathy • Tuberculosis • Patients with myasthenia gravis receiving anticholinesterase therapy since
Related documents
ABHB Prescribing Guideline Use of Transdermal Fentanyl Patches
www.wales.nhs.ukThis Guidance should be used in conjunction with the Summary of Product Characteristics (SmPC) for the particular brand of fentanyl patch being used.
OPIATE CONVERSION DOSES - NHS Wales
www.wales.nhs.ukSAJ October 2010. Page 1 of 1 OPIATE CONVERSION DOSES Note: these conversions are provided only as an approximate guide to equivalences and individual patient variability needs to be considered when
Opioid Conversion Ratios - Guide to Practice 2010
www.emrpcc.org.auFinal December 2010. For review June 2013 Opioid Conversion Ratios - Guide to Practice 2010 Released December 2010. ©2010. The EMR PCC grants permission to reproduce parts of this publication for clinical and educational use only, provided that the Eastern Metropolitan Region Palliative
Opioid Conversion Ratios - Guide to Practice 2013
www.emrpcc.org.auOpioid Conversion Ratios - Guide to Practice 2013 Released 1st October 2013 ©2013. The EMR PCC grants permission to reproduce parts of this publication for clinical and educational use only, provided that the Eastern Metropolitan Region Palliative
ORAL MORPHINE MILLIGRAM EQUIVALENT CONVERSION TABLE ...
www.ohiopmp.govCALCULATION OF DAILY MORPHINE EQUIVALENT DOSE (MED) Strength per Unit X (Number of Units/ Days Supply) X MME conversion factor = Daily
090714 opioid conversions - © palliativedrugs.com
www.palliativedrugs.comOpioid preparations Morphine Newly recommended for use first line both orally and subcutaneously. At doses approaching 600mg/24hours it may be preferable to switch to diamorphine for
There are various accepted methods used when switching to ...
www.palliativecareswo.caEquianalgesic Card All equivalencies are approximate; use this chart as a guideline only. Oral Routes: Ratio